Bumble Bee Study Does Not Affect Neonicotinoid Conclusions, EFSA Says

5 June 2013 --- EFSA has identified several weaknesses in a study, published by the UK Food and Environment Research Agency (FERA), which suggested that neonicotinoid pesticides do not have a major effect on bumble bee colonies under field conditions.

Given these weaknesses, the Authority considers that the study does not affect the conclusions reached by EFSA regarding risks for bees related to the use of the neonicotinoid pesticides thiamethoxam, clothianidin and imidacloprid, published in January 2013.

The Authority made the following points regarding the relevance of the study, Effects of neonicotinoid seed treatments on bumble bee colonies under field conditions (Thompson et al.), to the risk assessments published by EFSA:
•EFSA’s assessments covered the authorised uses of a number of plant protection products containing thiamethoxam, clothianidin and imidacloprid across the European Union. The FERA study looked at only one crop – oilseed rape – and two plant protection products – one containing clothianidin, the other imidacloprid – authorised for use in the UK. Furthermore, the test sites and surrounding areas used in the FERA study reflect a small sample of agricultural conditions in the UK and cannot be considered representative of conditions in other parts of the EU.
•Two important routes of exposure – dust and guttation – were not addressed by the FERA study.
•In its assessments, EFSA reached conclusions mainly for honey bees, and identified a data gap for other pollinators. Field studies of bumble bees cannot be used to understand the risks to honey bees and other pollinators because of significant species differences.

EFSA’s experts highlighted a number of other deficiencies in the report. These include:
•Inconsistencies and contradictory statements regarding the objectives of the study.
•Absence of suitable control bee colonies. In particular, analysis of residues in pollen and nectar showed that the “control” site had been contaminated by thiamethoxam.
•Environmental conditions were varied across the three the test sites, which reduces the sensitivity of the study in detecting effects on colonies.

EFSA also raised concerns about how Thompson et al. elaborated and interpreted the study results to reach their conclusions.

Related Articles

Business News

Lallemand Makes Two Acquisitions as Looks to Grow Business in Dairy and Meat and Bolster Position in Latin America

05 May 2016 --- Lallemand, the Canadian yeast and bacteria maker, has made two acquisitions as it looks to bolster its business in dairy and meat as well as enhance its business in Latin America.

Food Ingredients News

“The Clean Label Trend in the Dairy Market Will Continue,” Says KaTech

05 May 2016 --- Food technology company KaTech, bought by Katharina Hahn in 2012, specializes in convenience foods, and all aspects of dairy products, including the development of dairy-free alternatives. Providing an agile and highly confidential service to its clients, the company has built a reputation for its bespoke, customer solutions driven approach, and is now expanding into new areas.

Food Ingredients News

Frutarom Launches NutraT, Instant Drink Powders with Mediterranean Antioxidants

05 May 2016 --- Frutarom Health BU., have announced the launch of NutraT, the next-generation instant drink powder with all the benefits of a healthy Mediterranean diet.

Business News

Fonterra Cuts Farmgate Milk Price to Farmers as Hit by “Challenging” Global Dairy Market

05 May 2016 --- Fonterra, the New Zealand dairy co-operative, has reduced its forecast farmgate milk price to dairy farmers, saying the new pricing better reflects the oversupply of milk in the market which is impacting global diary commodity prices.

Business News

Royal DSM Makes Changes Across Nutrition as it Looks to Meet Ambitious Profit Targets

04 May 2016 --- Royal DSM, the Dutch vitamin giant, has appointed Jeremy Xu, the former executive at DuPont, to head up its Human Nutrition & Health business, in a further rejig of its nutrition arm at it looks to meet ambitious profit targets.

More Articles